Injections of stem cells from fat tissue to treat erectile dysfunction
Official title: Prospective Observational Study on Intracavernosal Injection of Autologous Adipose Tissue-Derived Stem Cells (ADSC) or Stem Cell-derived Exosomes for the Treatment of Erectile Dysfunction
Run by Jumeirah American Clinic · NCT06605508 · Data updated 2026-11-12
This study is testing if injections of stem cells from fat can help men aged 30 to 75 with erectile dysfunction who haven't found relief from other treatments.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 30 Years to 75 Years |
| Sex | Men only |
| Enrollment | 30 (estimated) |
| Sponsor | Jumeirah American Clinic Academic / other |
| Locations | 1 site (Dubai, Dubai) |
| Status | Recruiting |
| Started | January 10, 2025 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2029 |
| Registry record updated | August 26, 2025 |
| Trial ID | NCT06605508 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adult males aged 30 to 75 with mild to moderate erectile dysfunction and a history of inadequate response to PDE-5 inhibitors.
✕Probably not a fit
Patients with severe cardiovascular disease, active infections, or a history of malignancies may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the safety and effectiveness of injecting autologous adipose tissue-derived stem cells (ADSCs) or stem cell-derived exosomes into the penis for men aged 30 to 75 with erectile dysfunction (ED) who have not responded to standard treatments. Participants will receive these injections and undergo assessments to measure improvements in erectile function using the International Index of Erectile Function (IIEF) score, as well as blood flow changes monitored by Doppler ultrasound. Follow-up visits will occur at 3, 6, 9, and 12 months to track long-term effects and any potential side effects.
Why it matters
Potential benefit: If successful, this approach could provide a new treatment option for men with erectile dysfunction who do not respond to conventional therapies.
How similar studies have gone: While regenerative medicine approaches for erectile dysfunction are emerging, this specific method using ADSCs is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age: Adult males aged 30 to 75 years. * Diagnosis: Confirmed diagnosis of erectile dysfunction (ED) of mild to moderate severity, as defined by an International Index of Erectile Function (IIEF) score. * Treatment Response: Failure or suboptimal response to conventional ED treatments, such as PDE-5 inhibitors. * General Health: Overall good health without contraindications to stem cell therapy. * Informed Consent: Ability and willingness to provide written informed consent to participate in the study. Exclusion Criteria: * Severe Cardiovascular Disease: Presence of severe cardiovascular conditions, including uncontrolled hypertension or significant heart disease. * Active Infections: Ongoing infections that could interfere with treatment or pose a risk to the participant. * Malignancies: History of or current cancer, including malignancies that could affect safety or treatment outcomes. * Contraindications to Stem Cell Therapy: Any medical conditions or treatments that contraindicate the use of stem cell therapy. * Uncontrolled Diabetes: Poorly controlled diabetes or other metabolic disorders that could impact treatment efficacy or safety. * Psychiatric or Cognitive Impairments: Significant psychiatric or cognitive disorders that may affect the participant\'s ability to comply with study protocols or provide informed consent. * Recent Surgery or Trauma: Recent major surgeries or physical trauma that could impact the study or interfere with the intervention. * Participation in Other Studies: Participation in other clinical trials or studies that may affect the outcomes or safety of this study.
Where it's running
-
Jumeirah American Clinic
Dubai, Dubai, United Arab Emirates Recruiting
Study contacts
- Study coordinator: Ranjith Ramasamy, MD
- Email: ranjith.ramasamy@jac.ae
- Phone: +971 800 522823
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Platelet-Rich Plasma for Erectile Dysfunction After Prostate Surgery
This trial tests whether injecting a patient’s own platelet-rich plasma can improve erectile function in men who have persistent ED more than a year after nerve-sparing radical prostatectomy.
-
Comparing low-intensity shockwave and radial wave treatments for erectile dysfunction and pelvic pain
This study is testing whether focused shockwave therapy or radial wave therapy can help men with erectile dysfunction and people with chronic pelvic pain feel better.
-
HIP2602 for Erectile Dysfunction: Testing a new treatment in adults
This study tests whether HIP2602, alone or with related formulations, can improve erectile function in adult men with long-standing erectile dysfunction who partner with the same adult female partner.
-
Pudendal artery plaque and erectile dysfunction in men with heart disease
A small study tests whether plaque in the internal pudendal arteries is linked to erectile function in men with coronary artery disease who are undergoing coronary angiography.
-
Tractography-Guided Nerve-Sparing in Prostate Cancer
A nerve-sparing approach during prostate cancer surgery uses 3D nerve maps created from diffusion tensor imaging to guide the surgeon and see if preservation of nerves improves function.
-
Piezoelectric Low-Intensity Shockwave Therapy for erectile dysfunction in PDE5i nonresponders
This study tests whether four weeks of low‑intensity, linear piezoelectric shockwave therapy can improve erectile function in men with ED who did not respond to PDE5 inhibitors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.